English 
Arabic 
Strategy
Our strategy
We focus on finding new medicines and diagnostics that help patients live longer, better lives and evolve the practice of medicine.
We are guided by our purpose: Doing now what patients need next. Our company has a 30-year history of advancing the field of medicine and bringing novel treatments and diagnostics to patients. The patient is and will remain at the core of what we do, the reason we come to work every day.
What we do?
Our focus:
is on fitting treatments to patients: providing the right therapy for the right group of people at the right time. With our in-house combination of Pharmaceuticals and Diagnostics, we are uniquely positioned to deliver personalised healthcare. We are developing our internal capabilities and building strategic partnerships ready for the next stage in personalised healthcare: to combine insights from multiple data sources with sophisticated analytics to drive more effective and efficient research and allow for better therapeutic decisions for patients. Access to our products is also a critical part of our strategy. Our detailed access plans are embedded into the business at a local level.
We will continue to concentrate our energies entirely on prescription medicines and in vitro diagnostics, rather than diversify into other sectors like generics and biosimilars, over-the-counter medicines and medical devices
Our distinctiveness:
In our pursuit of excellence in science, our distinctiveness rests on four key elements: an exceptionally broad and deep understanding of molecular biology, the seamless integration of our pharmaceuticals and diagnostics capabilities, a diversity of approaches to maximise innovation, and a long-term orientation.
Our delivery:
Our delivery is to create value for all our stakeholders: being a partner of choice; bringing significant medical benefit for patients, doctors and payers; offering a great place to work for employees; having a sustainable impact on society; and creating top-quartile total shareholder return for our investors.
How we do it
Our people:
In the end, it takes people with integrity, courage and passion to make a difference for patients. It is our people who are proud to say: We are BADRAWY. We embrace the diversity of cultures and people across the Group. We are inclusive and encourage the richness of ideas and approaches this brings.
Our decision making:
Our decision-making principles and processes emphasise transparent dialogue, clear accountability, and encourage a high degree of empowerment.Our structure
Our structure:
is built for innovation. Our autonomous research and development centres and alliances with over 100 external partners foster diversity and agility. Our global geographical scale and reach enables us to bring our diagnostics and medicines quickly to people who need them.